Atlas Trials

Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC

Clinical trial NCT06711094 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06711094
Sponsor
Fujian Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HR+/HER2- Advanced Breast Cancer
Start date
2025-01-01
Primary completion
2027-12-30
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.